Resolution of azole-resistant oesophageal candidiasis in an AIDS patient after treatment with caspofungin.
Smith
Kate
K
Youle
Mike
M
Baker
Bob
B
Ballinger
Jayne
J
Cuthbertson
Zoe
Z
Johnson
Margaret
M
D017088:AIDS-Related Opportunistic Infections / Q000150:complications / Q000188:drug therapy*; D000328:Adult; D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D000935:Antifungal Agents / Q000627:therapeutic use*; D002177:Candidiasis / Q000150:complications* / Q000188:drug therapy*; D000077336:Caspofungin; D025141:Drug Resistance, Fungal; D054714:Echinocandins; D004935:Esophageal Diseases / Q000188:drug therapy* / Q000382:microbiology; D006801:Humans; D055666:Lipopeptides; D008297:Male; D009059:Mouth Diseases / Q000188:drug therapy* / Q000382:microbiology; D010455:Peptides; D010456:Peptides, Cyclic; D012008:Recurrence; D017211:Treatment Failure
D000900:Anti-Bacterial Agents; D000935:Antifungal Agents; D054714:Echinocandins; D055666:Lipopeptides; D010455:Peptides; D010456:Peptides, Cyclic; D000077336:Caspofungin